Novo-Nordisk ADR repsg 1 B
Stock
Stock
ISIN: US6701002056
Ticker: NVO
US6701002056
NVO
Price
Price
CHART BY
Historical dividends and forecast
The next dividend will be paid on 02.04.2025
$0.22
CHART BY
Frequently asked questions
What is Novo-Nordisk ADR repsg 1 B's market capitalization?
The market capitalization of Novo-Nordisk ADR repsg 1 B is $39.48B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Novo-Nordisk ADR repsg 1 B's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Novo-Nordisk ADR repsg 1 B is 27.71. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Novo-Nordisk ADR repsg 1 B?
Novo-Nordisk ADR repsg 1 B's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.427. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Novo-Nordisk ADR repsg 1 B's stock?
Currently, 31 analysts cover Novo-Nordisk ADR repsg 1 B's stock, with a consensus target price of $16.60. Analyst ratings provide insights into the stock's expected performance.
What is Novo-Nordisk ADR repsg 1 B's revenue over the trailing twelve months?
Over the trailing twelve months, Novo-Nordisk ADR repsg 1 B reported a revenue of $5.43B.
What is the EBITDA for Novo-Nordisk ADR repsg 1 B?
Novo-Nordisk ADR repsg 1 B's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $2.72B. EBITDA measures the company's overall financial performance.
What is the free cash flow of Novo-Nordisk ADR repsg 1 B?
Novo-Nordisk ADR repsg 1 B has a free cash flow of $1.56B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Novo-Nordisk ADR repsg 1 B have, and what sector and industry does it belong to?
Novo-Nordisk ADR repsg 1 B employs approximately 63,370 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Novo-Nordisk ADR repsg 1 B's shares?
The free float of Novo-Nordisk ADR repsg 1 B is 3.34B. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $39.48B
- EPS (TTM)
- $0.427
- Free Float
- 3.34B
- P/E ratio (TTM)
- 27.71
- Revenue (TTM)
- $5.43B
- EBITDA (TTM)
- $2.72B
- Free Cashflow (TTM)
- $1.56B
Pricing
- 1D span
- $86.69$88.59
- 52W span
- $81.50$148.14
Analyst Ratings
The price target is $16.60 and the stock is covered by 31 analysts.
Buy
22
Hold
6
Sell
3
Information
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
- Employees
- 63,370
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- US6701002056
- Primary Ticker
- NVO